CELANESE CORP (CE) Stock Fundamental Analysis

NYSE:CE • US1508701034

49.94 USD
+0.81 (+1.65%)
At close: Feb 27, 2026
49.94 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Fundamental Rating

3

CE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. Both the profitability and financial health of CE have multiple concerns. CE scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year CE was profitable.
  • CE had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CE reported negative net income in multiple years.
  • CE had a positive operating cash flow in 4 of the past 5 years.
CE Yearly Net Income VS EBIT VS OCF VS FCFCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B

1.2 Ratios

  • The Return On Assets of CE (-13.95%) is worse than 80.72% of its industry peers.
  • CE has a worse Return On Equity (-78.22%) than 87.95% of its industry peers.
  • CE's Return On Invested Capital of 3.60% is in line compared to the rest of the industry. CE outperforms 53.01% of its industry peers.
  • CE had an Average Return On Invested Capital over the past 3 years of 3.94%. This is below the industry average of 6.18%.
Industry RankSector Rank
ROA -13.95%
ROE -78.22%
ROIC 3.6%
ROA(3y)-1.58%
ROA(5y)3.65%
ROE(3y)-10.4%
ROE(5y)9.5%
ROIC(3y)3.94%
ROIC(5y)6.46%
CE Yearly ROA, ROE, ROICCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • CE's Operating Margin of 8.72% is in line compared to the rest of the industry. CE outperforms 51.81% of its industry peers.
  • CE's Operating Margin has declined in the last couple of years.
  • The Gross Margin of CE (21.33%) is worse than 62.65% of its industry peers.
  • In the last couple of years the Gross Margin of CE has declined.
Industry RankSector Rank
OM 8.72%
PM (TTM) N/A
GM 21.33%
OM growth 3Y-17.45%
OM growth 5Y-8.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.93%
GM growth 5Y-2.17%
CE Yearly Profit, Operating, Gross MarginsCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CE is destroying value.
  • The number of shares outstanding for CE remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, CE has less shares outstanding
  • CE has a worse debt/assets ratio than last year.
CE Yearly Shares OutstandingCE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
CE Yearly Total Debt VS Total AssetsCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • Based on the Altman-Z score of 1.49, we must say that CE is in the distress zone and has some risk of bankruptcy.
  • CE's Altman-Z score of 1.49 is on the low side compared to the rest of the industry. CE is outperformed by 62.65% of its industry peers.
  • The Debt to FCF ratio of CE is 12.55, which is on the high side as it means it would take CE, 12.55 years of fcf income to pay off all of its debts.
  • CE's Debt to FCF ratio of 12.55 is in line compared to the rest of the industry. CE outperforms 56.63% of its industry peers.
  • CE has a Debt/Equity ratio of 2.99. This is a high value indicating a heavy dependency on external financing.
  • CE's Debt to Equity ratio of 2.99 is on the low side compared to the rest of the industry. CE is outperformed by 86.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 12.55
Altman-Z 1.49
ROIC/WACC0.48
WACC7.57%
CE Yearly LT Debt VS Equity VS FCFCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.63 indicates that CE should not have too much problems paying its short term obligations.
  • CE's Current ratio of 1.63 is on the low side compared to the rest of the industry. CE is outperformed by 65.06% of its industry peers.
  • CE has a Quick Ratio of 1.04. This is a normal value and indicates that CE is financially healthy and should not expect problems in meeting its short term obligations.
  • CE has a Quick ratio of 1.04. This is in the lower half of the industry: CE underperforms 62.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.04
CE Yearly Current Assets VS Current LiabilitesCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

4

3. Growth

3.1 Past

  • CE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.86%.
  • The earnings per share for CE have been decreasing by -12.03% on average. This is quite bad
  • Looking at the last year, CE shows a decrease in Revenue. The Revenue has decreased by -7.16% in the last year.
  • Measured over the past years, CE shows a quite strong growth in Revenue. The Revenue has been growing by 11.03% on average per year.
EPS 1Y (TTM)-51.86%
EPS 3Y-36.78%
EPS 5Y-12.03%
EPS Q2Q%-53.79%
Revenue 1Y (TTM)-7.16%
Revenue growth 3Y-0.45%
Revenue growth 5Y11.03%
Sales Q2Q%-7%

3.2 Future

  • Based on estimates for the next years, CE will show a very strong growth in Earnings Per Share. The EPS will grow by 25.75% on average per year.
  • Based on estimates for the next years, CE will show a small growth in Revenue. The Revenue will grow by 1.44% on average per year.
EPS Next Y38.2%
EPS Next 2Y31.42%
EPS Next 3Y29.62%
EPS Next 5Y25.75%
Revenue Next Year0.13%
Revenue Next 2Y1.6%
Revenue Next 3Y0.67%
Revenue Next 5Y1.44%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CE Yearly Revenue VS EstimatesCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
CE Yearly EPS VS EstimatesCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

  • CE is valuated correctly with a Price/Earnings ratio of 12.42.
  • Based on the Price/Earnings ratio, CE is valued cheaply inside the industry as 87.95% of the companies are valued more expensively.
  • CE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.10.
  • CE is valuated reasonably with a Price/Forward Earnings ratio of 8.99.
  • 91.57% of the companies in the same industry are more expensive than CE, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, CE is valued rather cheaply.
Industry RankSector Rank
PE 12.42
Fwd PE 8.99
CE Price Earnings VS Forward Price EarningsCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CE is valued a bit cheaper than 61.45% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CE is valued cheaper than 96.39% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.34
EV/EBITDA 10.26
CE Per share dataCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CE's earnings are expected to grow with 29.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y31.42%
EPS Next 3Y29.62%

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.24%, CE is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.22, CE is paying slightly less dividend.
  • With a Dividend Yield of 0.24, CE pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.24%

5.2 History

  • The dividend of CE has a limited annual growth rate of 3.06%.
  • CE has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CE has decreased its dividend recently.
Dividend Growth(5Y)3.06%
Div Incr Years0
Div Non Decr Years1
CE Yearly Dividends per shareCE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • CE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of CE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-2.78%
EPS Next 2Y31.42%
EPS Next 3Y29.62%
CE Yearly Income VS Free CF VS DividendCE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B

CELANESE CORP

NYSE:CE (2/27/2026, 8:04:00 PM)

After market: 49.94 0 (0%)

49.94

+0.81 (+1.65%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-17
Earnings (Next)05-04
Inst Owners103.64%
Inst Owner Change-1.28%
Ins Owners0.29%
Ins Owner Change1.23%
Market Cap5.47B
Revenue(TTM)9.54B
Net Income(TTM)-3.09B
Analysts73.33
Price Target63.75 (27.65%)
Short Float %6.36%
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield 0.24%
Yearly Dividend2.81
Dividend Growth(5Y)3.06%
DP-2.78%
Div Incr Years0
Div Non Decr Years1
Ex-Date02-24
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.25%
Min EPS beat(2)-0.14%
Max EPS beat(2)6.64%
EPS beat(4)3
Avg EPS beat(4)17.03%
Min EPS beat(4)-0.14%
Max EPS beat(4)44.41%
EPS beat(8)4
Avg EPS beat(8)4.55%
EPS beat(12)6
Avg EPS beat(12)2.25%
EPS beat(16)8
Avg EPS beat(16)2.68%
Revenue beat(2)0
Avg Revenue beat(2)-3.84%
Min Revenue beat(2)-6.31%
Max Revenue beat(2)-1.36%
Revenue beat(4)1
Avg Revenue beat(4)-1.91%
Min Revenue beat(4)-6.31%
Max Revenue beat(4)2.89%
Revenue beat(8)1
Avg Revenue beat(8)-3.49%
Revenue beat(12)1
Avg Revenue beat(12)-4.02%
Revenue beat(16)3
Avg Revenue beat(16)-2.63%
PT rev (1m)1.12%
PT rev (3m)-3.95%
EPS NQ rev (1m)-0.39%
EPS NQ rev (3m)-9.39%
EPS NY rev (1m)-0.39%
EPS NY rev (3m)-6.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.85%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-3.44%
Valuation
Industry RankSector Rank
PE 12.42
Fwd PE 8.99
P/S 0.56
P/FCF 5.34
P/OCF 3.94
P/B 1.38
P/tB N/A
EV/EBITDA 10.26
EPS(TTM)4.02
EY8.05%
EPS(NY)5.56
Fwd EY11.12%
FCF(TTM)9.35
FCFY18.73%
OCF(TTM)12.68
OCFY25.38%
SpS88.68
BVpS36.11
TBVpS-31.32
PEG (NY)0.33
PEG (5Y)N/A
Graham Number57.15
Profitability
Industry RankSector Rank
ROA -13.95%
ROE -78.22%
ROCE 4.59%
ROIC 3.6%
ROICexc 3.9%
ROICexgc 6.84%
OM 8.72%
PM (TTM) N/A
GM 21.33%
FCFM 10.55%
ROA(3y)-1.58%
ROA(5y)3.65%
ROE(3y)-10.4%
ROE(5y)9.5%
ROIC(3y)3.94%
ROIC(5y)6.46%
ROICexc(3y)4.22%
ROICexc(5y)6.88%
ROICexgc(3y)8.3%
ROICexgc(5y)11.46%
ROCE(3y)5.03%
ROCE(5y)8.35%
ROICexgc growth 3Y-15.4%
ROICexgc growth 5Y-7.22%
ROICexc growth 3Y-10.69%
ROICexc growth 5Y-13.63%
OM growth 3Y-17.45%
OM growth 5Y-8.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.93%
GM growth 5Y-2.17%
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 12.55
Debt/EBITDA 7.29
Cap/Depr 47.03%
Cap/Sales 3.75%
Interest Coverage 250
Cash Conversion 85.63%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 1.04
Altman-Z 1.49
F-Score3
WACC7.57%
ROIC/WACC0.48
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.86%
EPS 3Y-36.78%
EPS 5Y-12.03%
EPS Q2Q%-53.79%
EPS Next Y38.2%
EPS Next 2Y31.42%
EPS Next 3Y29.62%
EPS Next 5Y25.75%
Revenue 1Y (TTM)-7.16%
Revenue growth 3Y-0.45%
Revenue growth 5Y11.03%
Sales Q2Q%-7%
Revenue Next Year0.13%
Revenue Next 2Y1.6%
Revenue Next 3Y0.67%
Revenue Next 5Y1.44%
EBIT growth 1Y-23%
EBIT growth 3Y-17.82%
EBIT growth 5Y1.39%
EBIT Next Year75.34%
EBIT Next 3Y25.85%
EBIT Next 5Y20.79%
FCF growth 1Y21.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.61%
OCF growth 3YN/A
OCF growth 5YN/A

CELANESE CORP / CE FAQ

What is the ChartMill fundamental rating of CELANESE CORP (CE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CE.


Can you provide the valuation status for CELANESE CORP?

ChartMill assigns a valuation rating of 8 / 10 to CELANESE CORP (CE). This can be considered as Undervalued.


Can you provide the profitability details for CELANESE CORP?

CELANESE CORP (CE) has a profitability rating of 2 / 10.


What is the earnings growth outlook for CELANESE CORP?

The Earnings per Share (EPS) of CELANESE CORP (CE) is expected to grow by 38.2% in the next year.


Is the dividend of CELANESE CORP sustainable?

The dividend rating of CELANESE CORP (CE) is 3 / 10 and the dividend payout ratio is -2.78%.